Ocular myasthenia

Ocular myasthenia
Synonyms	Ocular myasthenia gravis
Pronounce	N/A
Specialty	N/A
Symptoms	Ptosis, diplopia, eye muscle weakness
Complications	Generalized myasthenia gravis
Onset	Any age, commonly in adulthood
Duration	Chronic
Types	N/A
Causes	Autoimmune disease
Risks	Thymoma, thyroid disease, genetic predisposition
Diagnosis	Clinical examination, ice pack test, edrophonium test, serological tests
Differential diagnosis	Thyroid eye disease, multiple sclerosis, brainstem lesions
Prevention	N/A
Treatment	Acetylcholinesterase inhibitors, corticosteroids, immunosuppressants, thymectomy
Medication	Pyridostigmine, prednisone, azathioprine
Prognosis	Variable, can progress to generalized myasthenia gravis
Frequency	Rare
Deaths	N/A

Ocular Myasthenia is a subtype of Myasthenia Gravis, a neuromuscular disease that leads to fluctuating muscle weakness and fatigue. In the case of Ocular Myasthenia, the disease is limited to the muscles that control the eyes and eyelids, and symptoms are related to eyelid drooping, double vision, or both.

Symptoms

The primary symptoms of Ocular Myasthenia include ptosis (drooping of the upper eyelid) and diplopia (double vision). These symptoms may occur in one or both eyes. They may come and go over time, and they may vary in severity.

Causes

Ocular Myasthenia is caused by a breakdown in the normal communication between nerves and muscles. This breakdown is due to an autoimmune response where antibodies block, alter, or destroy the receptors for acetylcholine, a neurotransmitter that sends messages from nerve cells to muscle cells.

Diagnosis

Diagnosis of Ocular Myasthenia can be challenging due to the fluctuating nature of the symptoms. Tests that may be used in the diagnostic process include blood tests, Edrophonium test, nerve conduction studies, and imaging studies of the chest to rule out the presence of a thymoma.

Treatment

Treatment options for Ocular Myasthenia include medication, surgery, and other therapies. Medications may include cholinesterase inhibitors, which improve communication between nerves and muscles, and immunosuppressants, which reduce the production of abnormal antibodies. Surgery may be used to remove the thymus gland (thymectomy), which is often abnormal in people with myasthenia gravis. Other therapies may include plasmapheresis and intravenous immunoglobulin, which alter the immune system and provide temporary relief from symptoms.

Prognosis

The prognosis for individuals with Ocular Myasthenia varies. Some people may experience a complete remission of symptoms without treatment, while others may have a progression of symptoms to generalized myasthenia gravis. With treatment, most individuals with the condition have a normal life expectancy.

See Also

• Myasthenia Gravis
• Neuromuscular disease
• Autoimmune disease